137
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Use of pre-enrollment randomization and delayed consent to maximize participation in a clinical trial of opt-in versus opt-out tobacco treatment

, MD, MPHORCID Icon, , MPHORCID Icon, , MD, MPHORCID Icon, , MD, MPHORCID Icon, , MSORCID Icon, , PhDORCID Icon, , PhDORCID Icon, , PhDORCID Icon & , PhD, MPHORCID Icon show all

References

  • National Center for Chronic Disease P, Health Promotion Office on S, Health. Reports of the Surgeon General. In: The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention (US); 2014.
  • Dahm JL, Cook E, Baugh K, et al. Predictors of enrollment in a smoking cessation clinical trial after eligibility screening. J Natl Med Assoc. 2009;101(5):450–455.
  • Mak YW, Lee PH, Loke AY. Predictors of participation in a telephone-based acceptance and Commitment Therapy for smoking cessation study. BMC Public Health. 2015;15:1288.
  • Belisario M, Bruggeling JS, Gunn MN, Brusamento LH, Car S. J. Interventions for recruiting smokers into cessation programmes. Cochrane Database Syst Rev. 2012;12:CD009187.
  • Faseru B, Ellerbeck EF, Catley D, et al. Changing the default for tobacco-cessation treatment in an inpatient setting: study protocol of a randomized controlled trial. Trials 2017;18(1):379.
  • Zelen M. A new design for randomized clinical trials. N Engl J Med. 1979;300(22):1242–1245.
  • Andrew M, Vegh P, Caco C, et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr. 1993;123(2):285–291.
  • Adamson J, Cockayne S, Puffer S, Torgerson DJ. Review of randomised trials using the post-randomised consent (Zelen’s) design. Contemp Clin Trials. 2006;27(4):305–319.
  • Hatcher S, Coupe N, Wikiriwhi K, Durie SM, Pillai A. Te Ira Tangata: a Zelen randomised controlled trial of a culturally informed treatment compared to treatment as usual in Māori who present to hospital after self-harm. Soc Psychiatry Psychiatr Epidemiol. 2016;51(6):885–894.
  • Simon GE, Beck A, Rossom R, et al. Population-based outreach versus care as usual to prevent suicide attempt: study protocol for a randomized controlled trial. Trials. 2016;17(1):452.
  • Denison-Day J, Muir S, Newell C, Appleton KM. A Web-Based Intervention (MotivATE) to Increase Attendance at an Eating Disorder Service Assessment Appointment: Zelen Randomized Controlled Trial. J Med Internet Res. 2019;21(2):e11874.
  • Jongbloed K, Friedman AJ, Pearce ME, et al. The Cedar Project WelTel mHealth intervention for HIV prevention in young Indigenous people who use illicit drugs: study protocol for a randomized controlled trial. Trials. 2016;17(1):128.
  • Malliaras P, Cridland K, Hopmans R, et al. Internet and Telerehabilitation-Delivered Management of Rotator Cuff-Related Shoulder Pain (INTEL Trial): randomized controlled pilot and feasibility trial. JMIR Mhealth Uhealth. 2020;8(11):e24311.
  • Koutoukidis DA, Land J, Hackshaw A, et al. Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design. Br J Cancer. 2020;123(2):187–195.
  • Hüppe A, Zeuner C, Karstens S, Hochheim M, Wunderlich M, Raspe H. Feasibility and long-term efficacy of a proactive health program in the treatment of chronic back pain: a randomized controlled trial. BMC Health Serv Res. 2019;19(1):714.
  • Plutzer K, Spencer AJ. Efficacy of an oral health promotion intervention in the prevention of early childhood caries. Community Dent Oral Epidemiol. 2008;36(4):335–346.
  • Legrain S, Tubach F, Bonnet-Zamponi D, et al. A new multimodal geriatric discharge-planning intervention to prevent emergency visits and rehospitalizations of older adults: the optimization of medication in AGEd multicenter randomized controlled trial. J Am Geriatr Soc. 2011;59(11):2017–2028.
  • Simon GE, Shortreed SM, DeBar LL. Zelen design clinical trials: why, when, and how. Trials 2021;22(1):541.
  • Fiore MC, Jaen CR, Baker TB, et.al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: Department of Health and Human Services. Public Health Service; 2008.
  • Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47–55.
  • Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19):2560–2572.
  • Samuelson W, Zeckhauser R. Status quo bias in decisionmaking. J Risk Uncertainty. 1988;1(1):7–59.
  • Johnson EJ, Goldstein D. Medicine. Do defaults save lives? Science. 2003;302(5649):1338–1339.
  • Herbst N, Wiener RS, Helm ED, et al. Effectiveness of an opt-out electronic heath record-based tobacco treatment consult service at an Urban Safety Net Hospital. Chest 2020;158(4):1734–1741.
  • Greenberg MR, Greco NM, Batchelor TJ, et al. Physician-directed smoking cessation using patient “opt-out” approach in the emergency department: a pilot program. J Am Coll Emerg Physicians Open. 2020;1(5):782–789.
  • HHS. Basic HHS Policy for Protection of Human Research Subjects. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/common-rule-subpart-a-46104/index.html. Accessed July 28, 2021.
  • Reimaging Healthcare The University of Kansas Health System 2019 Annual Report https://secure.viewer.zmags.com/publication/215723a3#/215723a3/11. Accessed March 3, 2021.
  • Faseru B, Yeh H-W, Ellerbeck EE, Befort C, Richter KP. Prevalence and predictors of tobacco treatment in an academic medical center. Jt Comm J Qual Patient Saf Resources. 2009;35(11):551–557.
  • Faseru B, Turner M, Casey G, et al. Evaluation of a hospital-based tobacco treatment service: outcomes and lessons learned. J Hosp Med. 2011;6(4):211–218.
  • McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol. 2014;67(3):267–277.
  • (OHRP) OfHRP. Code of Federal Regulations, Title 45, Part 46: Protection of Human Subjects. HHS.gov. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#46.116. Published 2009. Accessed January 10, 2015.
  • de Leon J, Diaz FJ, Becoña E, Gurpegui M, Jurado D, Gonzalez-Pinto A. Exploring brief measures of nicotine dependence for epidemiological surveys. Addict Behav. 2003;28(8):1481–1486.
  • Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press; 1977.
  • Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Effect Sizes Rather than p-values. In: Introduction to meta‐analysis.2009:297–302.
  • Hasselblad V, Hedges LV. Meta-analysis of screening and diagnostic tests. Psychol Bull. 1995;117(1):167–178.
  • Annane D, Outin H, Fisch C, Bellissant E. The effect of waiving consent on enrollment in a sepsis trial. Intensive Care Med. 2004;30(2):321–324.
  • Harvey SE, Elbourne D, Ashcroft J, Jones CM, Rowan K. Informed consent in clinical trials in critical care: experience from the PAC-Man Study. Intensive Care Med. 2006;32(12):2020–2025.
  • Marshall LF, Maas AI, Marshall SB, et al. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J Neurosurg. 1998;89(4):519–525.
  • O’Hare F, Spark S, Flanagan Z, Heritier S, Curtis A, Zoungas S. Impact of informed consent content and length on recruitment of older adults into a community based primary prevention trial. Contemp Clin Trials Commun. 2018;11:89–94.
  • Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol. 2002;12(4):248–256.
  • Land J, McCourt O, Heinrich M, et al. The adapted Zelen was a feasible design to trial exercise in myeloma survivors. J Clin Epidemiol. 2020;125:76–83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.